Mera Pharmaceuticals, Inc.
MRPI · OTC
10/31/2020 | 10/31/2011 | 10/31/2010 | 10/31/2009 | |
|---|---|---|---|---|
| Market Cap | $0 | $1,096 | $1,369 | $2,736 |
| - Cash | $0 | $4 | $6 | $3 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $1,091 | $1,363 | $2,733 |
| Revenue | $0 | $303 | $289 | $599 |
| % Growth | -100% | 4.8% | -51.8% | – |
| Gross Profit | $0 | $286 | $243 | $571 |
| % Margin | – | 94.6% | 84.1% | 95.3% |
| EBITDA | $0 | -$188 | -$524 | -$134 |
| % Margin | – | -62% | -181.4% | -22.4% |
| Net Income | -$0 | -$188 | -$538 | -$193 |
| % Margin | – | -62% | -186.2% | -32.2% |
| EPS Diluted | 0 | -0 | -0.001 | -0 |
| % Growth | 100% | 60% | -150% | – |
| Operating Cash Flow | $0 | -$72 | $9 | -$26 |
| Capital Expenditures | $0 | -$2 | -$150 | -$24 |
| Free Cash Flow | $0 | -$74 | -$141 | -$51 |